{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:17:04Z","timestamp":1771665424239,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T00:00:00Z","timestamp":1531526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T00:00:00Z","timestamp":1531526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1244-z","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T15:20:06Z","timestamp":1531581606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation"],"prefix":"10.1186","volume":"15","author":[{"given":"William","family":"Schreiber-Stainthorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanhita","family":"Sinharay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharat","family":"Srinivasula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Clifford","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Di Mascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dima A.","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,14]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"publisher","first-page":"e0131353","DOI":"10.1371\/journal.pone.0131353","volume":"10","author":"R Granich","year":"2015","unstructured":"Granich R, Gupta S, Hersh B, Williams B, Montaner J, Young B, Zuniga JM. Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality burden; 1990-2013. PLoS One. 2015;10:e0131353.","journal-title":"PLoS One"},{"key":"1244_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/hiv.12421","volume":"18","author":"S Teeraananchai","year":"2017","unstructured":"Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017;18:256\u201366.","journal-title":"HIV Med"},{"key":"1244_CR3","unstructured":"UN Joint Programme on HIV\/AIDS. Global AIDS Update. 2016. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/global-AIDS-update-2016_en.pdf . Accessed 20 Jul 2017."},{"key":"1244_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/09540121.2016.1258451","volume":"29","author":"T Cornelius","year":"2017","unstructured":"Cornelius T, Jones M, Merly C, Welles B, Kalichman MO, Kalichman SC. Impact of food, housing, and transportation insecurity on ART adherence: a hierarchical resources approach. AIDS Care. 2017;29:449\u201357.","journal-title":"AIDS Care"},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11904-014-0220-1","volume":"11","author":"OA Uthman","year":"2014","unstructured":"Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV\/AIDS Rep. 2014;11:291\u2013307.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1244_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-014-0142-1","volume":"12","author":"N Langebeek","year":"2014","unstructured":"Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsd\u00f3ttir TB, Richter C, Sprangers MA, Nieuwkerk PT. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142.","journal-title":"BMC Med"},{"key":"1244_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/01.qai.0000147524.19122.fd","volume":"38","author":"LWH Yun","year":"2005","unstructured":"Yun LWH, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:432\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/QAD.0b013e328345889d","volume":"25","author":"SR Evans","year":"2011","unstructured":"Evans SR, Ellis RJ, Chen H, Yeh TM, Lee AJ, Schifitto G, Wu K, Bosch RJ, McArthur JC, Simpson DM, Clifford DB. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS. 2011;25:919\u201328.","journal-title":"AIDS"},{"key":"1244_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.antiviral.2009.10.016","volume":"85","author":"T Hawkins","year":"2010","unstructured":"Hawkins T. Understanding and managing the adverse effects of antiretroviral therapy. Antivir Res. 2010;85:201\u20139.","journal-title":"Antivir Res"},{"key":"1244_CR10","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1212\/01.WNL.0000038347.48137.67","volume":"59","author":"CH Hinkin","year":"2002","unstructured":"Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, Goetz MB, Stefaniak M. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944\u201350.","journal-title":"Neurology"},{"key":"1244_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/QAD.0b013e328354bed6","volume":"26","author":"BL Genberg","year":"2012","unstructured":"Genberg BL, Wilson IB, Bangsberg DR, Arnsten J, Goggin K, Remien RH, Simoni J, Gross R, Reynolds N, Rosen M, et al. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS. 2012;26:1415\u201323.","journal-title":"AIDS"},{"key":"1244_CR12","doi-asserted-by":"crossref","unstructured":"Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181\u20133.","DOI":"10.1097\/00002030-200106150-00015"},{"key":"1244_CR13","doi-asserted-by":"crossref","unstructured":"Wilson IB, Bangsberg DR, Shen J, Simoni JM, Reynolds NR, Goggin K, Gross R, Arnsten JH, Remien RH, Erlen JA, Liu H. Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study. J Acquir Immune Defic Syndr. 2013;64:448\u201354.","DOI":"10.1097\/QAI.0000000000000025"},{"key":"1244_CR14","doi-asserted-by":"publisher","first-page":"ofx070","DOI":"10.1093\/ofid\/ofx070","volume":"4","author":"S Kamal","year":"2017","unstructured":"Kamal S, Locatelli I, Wandeler G, Sehhat A, Bugnon O, Metral M, Du Pasquier R, Gutbrod K, Cavassini M, Schneider MP, Swiss HIVCS. The presence of human immunodeficiency virus-associated neurocognitive disorders is associated with a lower adherence to combined antiretroviral treatment. Open Forum Infect Dis. 2017;4:ofx070.","journal-title":"Open Forum Infect Dis"},{"key":"1244_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-6405-2-6","volume":"2","author":"M Gisslen","year":"2005","unstructured":"Gisslen M, Rosengren L, Hagberg L, Deeks SG, Price RW. Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Res Ther. 2005;2:6.","journal-title":"AIDS Res Ther"},{"issue":"Suppl 1","key":"1244_CR16","first-page":"44","volume":"10","author":"RW Price","year":"2004","unstructured":"Price RW, Deeks SG. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: clinical and pathogenetic implications for the central nervous system. J Neuro-Oncol. 2004;10(Suppl 1):44\u201351.","journal-title":"J Neuro-Oncol"},{"key":"1244_CR17","first-page":"208","volume":"16","author":"JA Munoz-Moreno","year":"2010","unstructured":"Munoz-Moreno JA, Fumaz CR, Prats A, Ferrer MJ, Negredo E, Perez-Alvarez N, Molto J, Gomez G, Garolera M, Clotet B. Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning? J Neuro-Oncol. 2010;16:208\u201318.","journal-title":"J Neuro-Oncol"},{"key":"1244_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1086\/529523","volume":"197","author":"JD Lundgren","year":"2008","unstructured":"Strategies for Management of Antiretroviral Therapy Study G, Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ cell counts and HIV RNA levels during follow-up. J Infect Dis. 2008;197:1145\u201355.","journal-title":"J Infect Dis"},{"key":"1244_CR19","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/S0140-6736(06)68887-9","volume":"367","author":"C Danel","year":"2006","unstructured":"Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in West Africa (Trivacan ANRS 1269 trial): a randomised trial. Lancet. 2006;367:1981\u20139.","journal-title":"Lancet"},{"key":"1244_CR20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","volume":"74","author":"KR Robertson","year":"2010","unstructured":"Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ, For the AST. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010;74:1260\u20136.","journal-title":"Neurology"},{"key":"1244_CR21","first-page":"550","volume":"14","author":"ME Childers","year":"2008","unstructured":"Childers ME, Woods SP, Letendre S, McCutchan JA, Rosario D, Grant I, Mindt MR, Ellis RJ, San Diego HIVNRCG. Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection. J Neuro-Oncol. 2008;14:550\u20137.","journal-title":"J Neuro-Oncol"},{"key":"1244_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","volume":"23","author":"CM Marra","year":"2009","unstructured":"Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009;23:1359\u201366.","journal-title":"AIDS"},{"key":"1244_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/QAI.0b013e3181af83d6","volume":"52","author":"V Tozzi","year":"2009","unstructured":"Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A. Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr. 2009;52:56\u201363.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1244_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1212\/WNL.0000000000000564","volume":"83","author":"EC Caniglia","year":"2014","unstructured":"Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, et al. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology. 2014;83:134\u201341.","journal-title":"Neurology"},{"key":"1244_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/WCO.0b013e32834695fb","volume":"24","author":"P Gannon","year":"2011","unstructured":"Gannon P, Khan MZ, Kolson DL. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol. 2011;24:275\u201383.","journal-title":"Curr Opin Neurol"},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","volume":"76","author":"N Ciccarelli","year":"2011","unstructured":"Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, Tamburrini E, Cauda R, De Luca A, Silveri MC. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76:1403\u20139.","journal-title":"Neurology"},{"key":"1244_CR27","first-page":"248","volume":"17","author":"TL Jernigan","year":"2011","unstructured":"Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, et al. Clinical factors related to brain structure in HIV: the CHARTER study. J Neuro-Oncol. 2011;17:248\u201357.","journal-title":"J Neuro-Oncol"},{"key":"1244_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/infdis\/jit006","volume":"207","author":"E Leeansyah","year":"2013","unstructured":"Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Velayudham P, Gouillou M, Spelman T, Hearps A, Fairley C, Smit de V, et al. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging. J Infect Dis. 2013;207:1157\u201365.","journal-title":"J Infect Dis"},{"key":"1244_CR29","doi-asserted-by":"publisher","first-page":"e95500","DOI":"10.1371\/journal.pone.0095500","volume":"9","author":"LA Brown","year":"2014","unstructured":"Brown LA, Jin J, Ferrell D, Sadic E, Obregon D, Smith AJ, Tan J, Giunta B. Efavirenz promotes beta-secretase expression and increased Abeta1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). PLoS One. 2014;9:e95500.","journal-title":"PLoS One"},{"key":"1244_CR30","first-page":"39","volume":"20","author":"C Akay","year":"2014","unstructured":"Akay C, Cooper M, Odeleye A, Jensen BK, White MG, Vassoler F, Gannon PJ, Mankowski J, Dorsey JL, Buch AM, et al. Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neuro-Oncol. 2014;20:39\u201353.","journal-title":"J Neuro-Oncol"},{"key":"1244_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/sti.77.3.158","volume":"77","author":"AJ White","year":"2001","unstructured":"White AJ. Mitochondrial toxicity and HIV therapy. Sex Transm Infect. 2001;77:158\u201373.","journal-title":"Sex Transm Infect"},{"key":"1244_CR32","doi-asserted-by":"publisher","first-page":"e85637","DOI":"10.1371\/journal.pone.0085637","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Song F, Gao Z, Ding W, Qiao L, Yang S, Chen X, Jin R, Chen D. Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons. PLoS One. 2014;9:e85637.","journal-title":"PLoS One"},{"key":"1244_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(03)14363-2","volume":"362","author":"S Iyengar","year":"2003","unstructured":"Iyengar S, Chin B, Margolick JB, Sabundayo BP, Schwartz DH. Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet. 2003;362:945\u201350.","journal-title":"Lancet"},{"key":"1244_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/MNM.0b013e3283331114","volume":"31","author":"M Sathekge","year":"2010","unstructured":"Sathekge M, Maes A, Kgomo M, Van de Wiele C. Fluorodeoxyglucose uptake by lymph nodes of HIV patients is inversely related to CD4 cell count. Nucl Med Commun. 2010;31:137\u201340.","journal-title":"Nucl Med Commun"},{"key":"1244_CR35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/01.aids.0000222070.52996.76","volume":"20","author":"D Brust","year":"2006","unstructured":"Brust D, Polis M, Davey R, Hahn B, Bacharach S, Whatley M, Fauci AS, Carrasquillo JA. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS. 2006;20:985\u201393.","journal-title":"AIDS"},{"key":"1244_CR36","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1073\/pnas.93.13.6425","volume":"93","author":"AM Scharko","year":"1996","unstructured":"Scharko AM, Perlman SB, PWn H, Hanson JM, Uno H, Pauza CD. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci U S A. 1996;93:6425\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1244_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00259-008-1023-7","volume":"36","author":"G Lucignani","year":"2009","unstructured":"Lucignani G, Orunesu E, Cesari M, Marzo K, Pacei M, Bechi G, Gori A, Gaito S, Clerici M, Chiti A. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging. 2009;36:640\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1244_CR38","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/archneur.57.11.1601","volume":"57","author":"HJ von Giesen","year":"2000","unstructured":"von Giesen HJ, Antke C, Hefter H, Wenserski F, Seitz RJ, Arendt G. Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch Neurol. 2000;57:1601\u20137.","journal-title":"Arch Neurol"},{"key":"1244_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1742-2094-7-13","volume":"7","author":"AB Andersen","year":"2010","unstructured":"Andersen AB, Law I, Krabbe KS, Bruunsgaard H, Ostrowski SR, Ullum H, Hojgaard L, Lebech A, Gerstoft J, Kjaer A. Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients. J Neuroinflammation. 2010;7:13.","journal-title":"J Neuroinflammation"},{"key":"1244_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000095222","volume":"13","author":"AB Andersen","year":"2006","unstructured":"Andersen AB, Law I, Ostrowski SR, Lebech AM, Hoyer-Hansen G, Hojgaard L, Gerstoft J, Ullum H, Kjaer A. Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalities. Neuroimmunomodulation. 2006;13:69\u201375.","journal-title":"Neuroimmunomodulation"},{"key":"1244_CR41","first-page":"1575","volume":"38","author":"MJ O'Doherty","year":"1997","unstructured":"O'Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997;38:1575\u201383.","journal-title":"J Nucl Med"},{"key":"1244_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1176\/jnp.4.3.280","volume":"4","author":"WG van Gorp","year":"1992","unstructured":"van Gorp WG, Mandelkern MA, Gee M, Hinkin CH, Stern CE, Paz DK, Dixon W, Evans G, Flynn F, Frederick CJ, et al. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci. 1992;4:280\u20137.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1244_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","volume":"70","author":"S Vaidyanathan","year":"2015","unstructured":"Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET\/CT in infection and inflammation--current and emerging clinical applications. Clin Radiol. 2015;70:787\u2013800.","journal-title":"Clin Radiol"},{"key":"1244_CR44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1901","volume":"6","author":"TA Waldmann","year":"2006","unstructured":"Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6:595\u2013601.","journal-title":"Nat Rev Immunol"},{"key":"1244_CR45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.micinf.2011.10.006","volume":"14","author":"PY Perera","year":"2012","unstructured":"Perera PY, Lichy JH, Waldmann TA, Perera LP. The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect. 2012;14:247\u201361.","journal-title":"Microbes Infect"},{"issue":"Suppl 2","key":"1244_CR46","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/00002030-200102002-00005","volume":"15","author":"RT Mitsuyasu","year":"2001","unstructured":"Mitsuyasu RT. The potential role of interleukin-2 in HIV. AIDS. 2001;15(Suppl 2):S22\u20137.","journal-title":"AIDS"},{"key":"1244_CR47","first-page":"219","volume":"21","author":"YM Mueller","year":"2010","unstructured":"Mueller YM, Katsikis PD. IL-15 in HIV infection: pathogenic or therapeutic potential? Eur Cytokine Netw. 2010;21:219\u201321.","journal-title":"Eur Cytokine Netw"},{"key":"1244_CR48","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI85996","volume":"126","author":"SA Younes","year":"2016","unstructured":"Younes SA, Freeman ML, Mudd JC, Shive CL, Reynaldi A, Panigrahi S, Estes JD, Deleage C, Lucero C, Anderson J, et al. IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. J Clin Invest. 2016;126:2745\u201356.","journal-title":"J Clin Invest"},{"key":"1244_CR49","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ni.2449","volume":"13","author":"AM Ring","year":"2012","unstructured":"Ring AM, Lin JX, Feng D, Mitra S, Rickert M, Bowman GR, Pande VS, Li P, Moraga I, Spolski R, et al. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat Immunol. 2012;13:1187\u201395.","journal-title":"Nat Immunol"},{"key":"1244_CR50","doi-asserted-by":"publisher","first-page":"e0167091","DOI":"10.1371\/journal.pone.0167091","volume":"11","author":"S Swaminathan","year":"2016","unstructured":"Swaminathan S, Qiu J, Rupert AW, Hu Z, Higgins J, Dewar RL, Stevens R, Rehm CA, Metcalf JA, Sherman BT, et al. Interleukin-15 (IL-15) strongly correlates with increasing HIV-1 viremia and markers of inflammation. PLoS One. 2016;11:e0167091.","journal-title":"PLoS One"},{"key":"1244_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0463.2006.apm_108.x","volume":"114","author":"MA Orsilles","year":"2006","unstructured":"Orsilles MA, Pieri E, Cooke P, Caula C. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy. APMIS. 2006;114:55\u201360.","journal-title":"APMIS"},{"key":"1244_CR52","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/S0140-6736(97)10291-4","volume":"351","author":"TS Li","year":"1998","unstructured":"Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet. 1998;351:1682\u20136.","journal-title":"Lancet"},{"key":"1244_CR53","first-page":"419","volume":"66","author":"L Belkhir","year":"2011","unstructured":"Belkhir L, Jonckheere S, Lhommel R, Vandercam B, Yombi JC. High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease. Acta Clin Belg. 2011;66:419\u201321.","journal-title":"Acta Clin Belg"},{"key":"1244_CR54","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/00002030-200007070-00008","volume":"14","author":"H Hatano","year":"2000","unstructured":"Hatano H, Vogel S, Yoder C, Metcalf JA, Dewar R, Davey RT Jr, Polis MA. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS. 2000;14:1357\u201363.","journal-title":"AIDS"},{"key":"1244_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1126\/science.277.5322.112","volume":"277","author":"B Autran","year":"1997","unstructured":"Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277:112\u20136.","journal-title":"Science"},{"key":"1244_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2249.2000.01201.x","volume":"120","author":"N Amirayan-Chevillard","year":"2000","unstructured":"Amirayan-Chevillard N, Tissot-Dupont H, Capo C, Brunet C, Dignat-George F, Obadia Y, Gallais H, Mege JL. Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin Exp Immunol. 2000;120:107\u201312.","journal-title":"Clin Exp Immunol"},{"key":"1244_CR57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/135965350300800103","volume":"8","author":"L Chang","year":"2003","unstructured":"Chang L, Ernst T, Witt MD, Ames N, Walot I, Jovicich J, DeSilva M, Trivedi N, Speck O, Miller EN. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antivir Ther. 2003;8:17\u201326.","journal-title":"Antivir Ther"},{"key":"1244_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","volume":"27","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"1244_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.aids.0000432467.54003.f7","volume":"28","author":"LJ Garvey","year":"2014","unstructured":"Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, Winston A. Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS. 2014;28:67\u201372.","journal-title":"AIDS"},{"key":"1244_CR60","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1212\/WNL.0000000000002485","volume":"86","author":"JH Vera","year":"2016","unstructured":"Vera JH, Guo Q, Cole JH, Boasso A, Greathead L, Kelleher P, Rabiner EA, Kalk N, Bishop C, Gunn RN, et al. Neuroinflammation in treated HIV-positive individuals: a TSPO PET study. Neurology. 2016;86:1425\u201332.","journal-title":"Neurology"},{"key":"1244_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1568010033344480","volume":"2","author":"P Amerio","year":"2003","unstructured":"Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pita O, Puddu P. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy. 2003;2:81\u201394.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"1244_CR62","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1084\/jem.168.6.2251","volume":"168","author":"B Sherry","year":"1988","unstructured":"Sherry B, Tekamp-Olson P, Gallegos C, Bauer D, Davatelis G, Wolpe SD, Masiarz F, Coit D, Cerami A. Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J Exp Med. 1988;168:2251\u20139.","journal-title":"J Exp Med"},{"key":"1244_CR63","first-page":"456","volume":"64","author":"M Bickel","year":"1993","unstructured":"Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol. 1993;64:456\u201360.","journal-title":"J Periodontol"},{"key":"1244_CR64","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","volume":"180","author":"KN Couper","year":"2008","unstructured":"Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771\u20137.","journal-title":"J Immunol"},{"key":"1244_CR65","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Department of Health and Human Services. 2017. https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf . Accessed 5 Dec 2017."}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1244-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T16:24:19Z","timestamp":1661617459000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1244-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,14]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1244-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,14]]},"assertion":[{"value":"23 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Animal Care and Use Committee of the National Institutes of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"207"}}